While every patient hopes to be seen by a doctor with the perfect blend of diagnostic skills and empathy, good bedside manner isn’t always a given, […]

Akira Endo, PhD, the Japanese microbiologist and biochemist known as the father of statins, died at the age of 90 on June 5. His research led […]

At the same time the Medicare population is growing, the number of family practice (FP) physicians and the number of procedures they perform are decreasing, according […]

ORLANDO, Fla. — Using fixed-ratio insulin combinations (FRC) can reduce side effects such as nausea in treating diabetes, an advantage that should persuade clinicians to consider […]

ORLANDO, Fla. — The inhaled insulin Afrezza combined with a long-acting basal analog offers a non-inferior insulin treatment option for people with type 1 diabetes, new […]

ORLANDO, Fla. — The glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Wegovy, Ozempic) reduced cardiovascular events and reduced the risk of progression to diabetes by 73% […]

ORLANDO, Fla. — Patients with type 1 and 2 diabetes who delay treatment with recommended statin therapy to address the well-known high risk for cardiovascular (CV) […]

ORLANDO, Fla. — The old, generic cholesterol drug fenofibrate has shown potential for slowing the progression of diabetic retinopathy in people with early retinal changes, with […]

ORLANDO, FL — Continuous glucose monitoring (CGM) of hospitalized patients with diabetes could provide early and important clues about changing insulin needs and reduce the need […]